首頁 > 市場調查報告書 > 醫療設備

生技設備

切片檢查設備市場規模、佔有率和成長分析（按產品、引導技術、應用、最終用途和地區分類）—2026-2033年產業預測

市場調查報告書

商品編碼

1896782

切片檢查設備市場規模、佔有率和成長分析（按產品、引導技術、應用、最終用途和地區分類）—2026-2033年產業預測

Biopsy Devices Market Size, Share, and Growth Analysis, By Product, By Guidance Technique, By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 193 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，切片檢查設備市場規模將達到 75.2 億美元，到 2025 年將達到 85.8 億美元，到 2033 年將達到 244.7 億美元，預測期（2026-2033 年）的複合年成長率為 14%。

切片檢查設備市場的發展主要受各種癌症發生率上升和技術融合程度提高的驅動。作為診斷癌症和乳糜瀉等疾病的關鍵外科手術，切片檢查設備，尤其是肝臟、腎臟和肺等器官切片檢查所需的專業活體組織切片儀器，需求旺盛。 CT電腦斷層掃描、MRI和超音波等先進影像技術的融合提高了活體組織切片的準確性，並最大限度地減少了切片檢查的侵入性。 3D光學切片和MRI靶向切片檢查等新興技術備受關注，並推動了診斷精準度的提升。然而，切片檢查設備高成本以及發展中地區缺乏訓練有素的專業人員等挑戰依然存在，這些都可能阻礙市場成長。

全球切片檢查設備市場按產品、引導技術、應用、最終用戶和地區進行細分。按產品分類，市場分為液態生物檢體設備、針式切片檢查設備、手術托盤、立體定位導絲、切片檢查台、切片檢查鉗和其他產品。依引導技術分類，市場分為非影像引導切片檢查和影像引導切片檢查技術。依應用分類，市場分為肺癌、乳癌、大腸癌、腎癌、攝護腺癌、骨髓切片檢查和其他應用。按最終用戶分類，市場分為醫院和乳房護理中心、診斷影像中心、學術和研究機構以及其他最終用戶。按地區分類，市場分為北美、歐洲、亞太、中東和非洲以及拉丁美洲。

切片檢查設備市場促進因素

全球癌症發生率的不斷上升是切片檢查設備市場成長的主要驅動力。隨著癌症發生率的增加，對精準早期診斷工具的需求也隨之成長，凸顯了及時介入患者照護的必要性。這種對切片檢查需求的成長推動了創新切片檢查設備的研發和應用，從而促進了市場成長。對有效診斷和改進治療方法的迫切需求，為該領域先進技術的發展創造了有利環境，提高了醫療機構中切片檢查設備的整體可用性和利用率。

切片檢查設備市場的限制

許多發展中地區尖端切片檢查技術的普及程度有限，嚴重限制了切片檢查設備市場的成長。經濟挑戰和醫療基礎設施落後共同限制了現代切片檢查設備的供應和應用。這種資源匱乏不僅影響了設備的即時使用，也阻礙了市場的整體擴張，因為這些地區的醫療服務提供者面臨著阻礙先進診斷工具普及的許多障礙。因此，這些因素嚴重阻礙因素了服務不足地區切片檢查設備市場的發展和潛力。

切片檢查設備市場趨勢

由於超音波和電腦斷層掃描等影像導引切片檢查技術具有高精度和即時成像功能，其應用已成為切片檢查設備市場的一大趨勢。這項技術進步不僅提高了診斷準確率，也對患者預後產生了正面影響。隨著醫療機構逐漸認知到這些創新技術的優勢，對先進切片檢查設備的需求預計將大幅成長。微創手術的趨勢，以及精準診斷在腫瘤學和其他領域日益成長的重要性，正在推動市場成長並改變切片檢查設備的模式。

液態生物檢體裝置
針式切片檢查裝置
- 核心切片檢查裝置
- 核心切片穿刺針
- 核心切片檢查槍
- 抽吸切片穿刺針
- 真空輔助切片檢查裝置
- 真空輔助切片檢查系統
- 真空輔助切片穿刺針
治療托盤
位置確認線
切片檢查
切片檢查鉗
- 普通切片檢查鉗
- 高溫切片檢查鉗
其他產品

按引導技術分類的切片檢查設備市場

非影像引導切片檢查
影像引導切片檢查
- 超音波引導下切片檢查
- 立體定位引導切片檢查
- 磁振造影引導切片檢查
- 其他影像引導切片檢查技術

按應用分類的切片檢查設備市場

肺癌
乳癌
大腸直腸癌
腎癌
攝護腺癌
骨髓切片檢查
其他用途

按最終用戶分類的切片檢查設備市場

醫院及乳房護理中心
診斷影像中心
學術和研究機構
其他最終用戶

按地區分類的切片檢查設備市場規模

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Becton, Dickinson and Company（US）
Danaher Corporation（US）
B. Braun Melsungen AG（Germany）
Cardinal Health, Inc.（US）
Hologic, Inc.（US）
Olympus Corporation（Japan）
Boston Scientific Corporation（US）
Fujifilm Corporation（Japan）
Medtronic Plc（Ireland）
Stryker Corporation（US）
Cook Group Incorporated（US）
Argon Medical Devices（US）
Inrad, Inc.（US）
Conmed Corporation（US）
Teleflex Incorporated（US）
Qiagen NV（Netherlands）
Thermo Fisher Scientific, Inc.（US）
Summit Medical LLC（US）
Hill-Rom Holdings, Inc.（US）
Gallini SRL（Italy）
Transmed7, LLC（US）
TSK Laboratory International（Japan）
Merit Medical Systems, Inc.（US）
DR. Japan Co., Ltd.（Japan）
IZI Medical Products（US）
Planmed Oy（Finland）
Advin Health Care（India）
F. Hoffmann-La Roche Ltd.（Switzerland）
Bio-Rad Laboratories, Inc.（US）
Illumina, Inc.（US）

簡介目錄

Product Code: SQMIG35A2955

Biopsy Devices Market size was valued at USD 7.52 Billion in 2024 and is poised to grow from USD 8.58 Billion in 2025 to USD 24.47 Billion by 2033, growing at a CAGR of 14% during the forecast period (2026-2033).

The biopsy devices market is driven by the increasing prevalence of various cancers and advancements in technological integration. As a critical surgical method for diagnosing diseases like cancer and coeliac disease, the demand for specialized biopsy instruments is robust, particularly for organ biopsies of the liver, kidneys, and lungs. The incorporation of advanced imaging technologies such as CT scans, MRIs, and ultrasound enhances the precision and minimizes the invasiveness of biopsy procedures. Emerging methods like 3D optical and MRI-targeted biopsies are gaining traction, supporting the trend towards more accurate diagnostics. However, challenges remain, including the high cost of biopsy equipment and a shortage of trained professionals in developing regions, which can impede market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biopsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biopsy Devices Market Segments Analysis

Global Biopsy Devices Market is segmented on the product, guidance technique, application, end user, and region. By Product, Market is segmented into Liquid Biopsy Instruments, Needle-Based Biopsy Instruments, Procedure Trays, Localization Wires, Biopsy Tables, Biopsy Forceps, and Other Products. By Guidance Technique, Market for biopsy procedures is segmented into Non-Image-Guided Biopsy and Image-Guided Biopsy techniques. By Application, market is segmented into Lung Cancer, Breast Cancer, Colorectal Cancer, Kidney Cancer, Prostate Cancer, Bone Marrow Biopsy, and Other Applications. By End User, the Market is segmented into Hospitals & Breast Care Centers, Diagnostic Imaging Centers, Academic & Research Institutes, and Other End Users. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver of the Biopsy Devices Market

The biopsy devices market is largely propelled by the rising occurrence of cancer worldwide. As cancer rates escalate, the demand for accurate and early diagnostic tools intensifies, highlighting the necessity for timely intervention in patient care. This increasing requirement for biopsies fuels the advancement and adoption of innovative biopsy devices, thus driving market growth. The urgency for effective diagnostics and improved treatment options creates a flourishing environment for the development of advanced technologies in this sector, thereby enhancing the overall landscape of biopsy device offerings and their utilization in medical practices.

Restraints in the Biopsy Devices Market

The growth of the biopsy devices market is significantly impeded in numerous developing regions due to restricted access to cutting-edge biopsy technologies. Economic challenges coupled with underdeveloped healthcare infrastructures limit both the availability and adoption of modern biopsy instruments. This lack of accessibility not only affects the immediate use of such devices but also influences their overall market expansion, as healthcare providers in these areas face barriers that prevent the integration of advanced diagnostic tools. Consequently, these factors create a notable restraint in the progression and potential of the biopsy devices market in these underserved locations.

Market Trends of the Biopsy Devices Market

The Biopsy Devices market is witnessing a notable trend towards the adoption of image-guided biopsy techniques, such as ultrasound and CT scan guidance, due to their enhanced accuracy and real-time imaging capabilities. This technological advancement is not only improving diagnostic precision but also positively impacting patient outcomes. As healthcare providers increasingly recognize the benefits of these innovative methods, the demand for advanced biopsy equipment is expected to surge. This shift towards minimally invasive procedures, combined with a growing emphasis on precise diagnostics in oncology and other fields, is propelling growth and transforming the biopsy device landscape.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Patent Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Technology Analysis
Case Study Analysis
Pricing Analysis

Biopsy Devices Market, By Product

Market Overview
Liquid Biopsy Instruments
Needle-Based Biopsy Instruments
- Core Biopsy Devices
- Core Biopsy Needles
- Core Biopsy Guns
- Aspiration Biopsy Needles
- Vacuum-Assisted Biopsy Devices
- Vacuum-Assisted Biopsy Systems
- Vacuum-Assisted Biopsy Needles
Procedure Trays
Localization Wires
Biopsy Tables
Biopsy Forceps
- General Biopsy Forceps
- Hot Biopsy Forceps
Other Products

Biopsy Devices Market, By Guidance Technique

Market Overview
Non-Image-Guided Biopsy
Image-Guided Biopsy
- Ultrasound-Guided Biopsy
- Stereotactic-Guided Biopsy
- Mri-Guided Biopsy
- Other Image-Guided Biopsy Techniques

Biopsy Devices Market, By Application

Market Overview
Lung Cancer
Breast Cancer
Colorectal Cancer
Kidney Cancer
Prostate Cancer
Bone Marrow Biopsy
Other Applications

Biopsy Devices Market, By End User

Market Overview
Hospitals & Breast Care Centers
Diagnostic Imaging Centers
Academic & Research Institutes
Other End Users

Biopsy Devices Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Group Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Argon Medical Devices (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Inrad, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conmed Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Summit Medical LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hill-Rom Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gallini S.R.L (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Transmed7, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TSK Laboratory International (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DR. Japan Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IZI Medical Products (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Advin Health Care (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments